Brain-on-a-Chip. When brain cells are introduced onto the chip, they can use the nanowire as scaffolding to build functional neuronal circuits that mimic the interconnectivity of neurons in the brain. Once the lattice is constructed, researchers can not only observe the connectivity as-is but study the impact of disease and trauma.

In 2021, the global Brain-on-a-chip market size will be US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027.
This report focuses on the global Brain-on-a-chip status, future forecast, growth opportunity, key market, and key players. The study objectives are to present the Brain-on-a-chip development in North America, Europe, Japan, China, Southeast Asia, India, etc.

Global Brain-on-a-chip Scope and Market Size
Brain-on-a-chip market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Brain-on-a-chip market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Therapeutic Brain-on-a-chip
Enhanced Brain-on-a-chip

Segment by Application
Pharmaceutical & Biotechnology Companies
Academic & Research Institutes
Other End Users

By Region
North America
Europe
Japan
China
Southeast Asia
India

By Company
Emulate
Tissuse
Hesperos
CN Bio Innovations
Draper Laboratory
Mimetas
Nortis
Kirkstall
Cherry Biotech SAS
Else Else Kooi Laboratory